Diagnos Inc.
DGNOF
$0.142
$0.00674.95%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -3.07M | -2.74M | -2.47M | -2.28M | -2.31M |
Total Depreciation and Amortization | 92.20K | 93.80K | 96.70K | 94.40K | 92.10K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 548.10K | 587.50K | 542.20K | 531.90K | 515.50K |
Change in Net Operating Assets | -170.20K | -63.50K | 8.10K | -34.70K | 115.10K |
Cash from Operations | -2.60M | -2.12M | -1.82M | -1.69M | -1.59M |
Capital Expenditure | -9.90K | -9.60K | -7.90K | -7.10K | -8.10K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -2.24M | -1.85M | -1.25M | -145.90K | -3.80K |
Cash from Investing | -2.25M | -1.86M | -1.25M | -152.90K | -11.90K |
Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 843.80K |
Total Debt Repaid | -380.60K | -159.70K | -155.30K | -146.10K | -133.10K |
Issuance of Common Stock | 7.28M | 5.90M | 5.00M | 2.68M | 1.64M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -285.40K | -298.10K | -302.50K | -286.40K | -262.50K |
Cash from Financing | 4.76M | 3.97M | 3.33M | 1.65M | 1.55M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -88.10K | -16.40K | 259.30K | -190.00K | -58.00K |